2029 Disease Drug Development Pharmaceuticals 
Drug Discovery World
JANUARY 9, 2024
Thirteen new-to-market therapeutics and drugs poised to launch in 2024 will achieve ‘blockbuster’ status by 2029 or deliver game-changing benefits to patients. Due to a delayed US launch it remains a drug to watch for 2024.
Vial
MARCH 1, 2024
Introduction Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). billion by 2029. It ensures regulatory compliance for over 15 long-term post-authorization safety studies across eight disease indications. with full-year revenue of US$23.04 of total revenue).
Agency IQ
FEBRUARY 2, 2024
BY LAURA DIANGELO, MPH | JAN 30, 2024 10:25 AM CST Diagnostic regulation: A quick overview Diagnostics products are those intended to identify, signal or detect a specific health condition, infection or disease, or monitor a person’s health or health status. This is an extremely recent development, and an emerging area.
Expert insights. Personalized for you.
173 
Let's personalize your content